Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS Immunology
Study data from University of Manitoba, Department of Medical Microbiology update understanding of HIV/AIDS immunology
October 29th, 2008
New investigation results, 'Substantial intrapatient differences in the breadth and specificity of HIV-specific CD8+ T-cell interferon-gamma and proliferation responses,' are detailed in a study published in Journal of Acquired Immune Deficiency Syndromes. According to a study from Winnipeg, Canada, "HIV vaccine design and evaluation require a better understanding of protective immune responses. HIV-specific CD8+ T-cell responses have been characterized extensively using interferon-gamma (IFN-gamma) enzyme-linked immunosorbent spot (ELISPOT) assays, which do not always correlate with control of viral replication or disease progression." "Alternative aspects of...
Source: Vaccine Weekly (2008-10-29)
|
